European Cancer Market Outlook


Regular Price: USD 4,950.00

Special Price USD 3,465.00

30% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 3,465.00


Be the first to review this product

This research service analyses the European cancer drugs therapeutics market. The base year is 2010 with forecasts running through 2017. It analyses market drivers, restraints and challenges faced by industry participants. Total revenue forecasts of the cancer drugs market in Europe and pipeline analysis have been discussed. An overview of key cancer indications and treatment options are also provided. Moreover, it provides strategic recommendations for market players. Furthermore, it provides decision support databases which is a collection of multiple tables that cover a sector's demand, supply, select customer demographics and pertinent economic measurements.

Table of Contents

European Cancer Market Outlook, Executive SummarySummary of the European Cancer MarketsExecutive Summary of the European Cancer MarketsEuropean Cancer Market Outlook, Research Methodology Methodology of ResearchMethodologyEuropean Cancer Market Outlook, Total European Cancer MarketIntroductionScope and SegmentationAssumptions and LimitationsGlossary of Terms and AbbreviationsEpidemiologyCancer Treatment Pathways Market Trends and DynamicsMarket OverviewKey Trends in Cancer TherapeuticsKey Trends in Cancer DiagnosticsMarket Engineering MeasurementsIndustry ChallengesMarket DriversMarket RestraintsRevenue ForecastsEuropean Cancer Market Outlook, Key Cancer IndicationsMajor Cancer Types and Treatment OptionsCancer Indications - OverviewLung CancerColorectal CancerBreast CancerOvarian CancerProstate CancerPancreatic CancerHodgkin's Disease (HD) and Non-Hodgkin's Lymphoma (NHL)Head and Neck CancerCurrent Therapeutic OptionsAnti-cancer Drugs Available in EuropeEuropean Cancer Market Outlook, Key Emerging TherapeuticsKey Anti- Cancer Drug TherapeuticsKey Emerging Anti-Cancer Drug TherapiesEuropean Cancer Market Outlook, Cancer Market Analysis by CountryCountry-wise Cancer Market AnalysisAnalysis of Cancer Market in GermanyAnalysis of Cancer Market in the United Kingdom Analysis of Cancer Market in FranceAnalysis of Cancer Market in ItalyAnalysis of Cancer Market in SpainEuropean Cancer Market Outlook, Competitive LandscapeProduct ProfilesKey Anti- Cancer Brands in the European Cancer MarketEuropean Cancer Market Outlook, Market Engineering StrategyStrategic Analysis and RecommendationsStrategic RecommendationsEuropean Cancer Market Outlook, Decision Support DatabasesDatabases for AnalysisTotal Healthcare Expenditure Private Healthcare ExpenditurePublic Healthcare ExpenditurePer Capita Healthcare ExpenditurePercent Healthcare Expenditure in GDP

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.